Complex karyotype is a stronger predictor than del(17p) for an inferior outcome in relapsed or refractory chronic lymphocytic leukemia patients treated with ibrutinib-based regimens

Philip A. Thompson, Susan M. O'Brien, William G. Wierda, Alessandra Ferrajoli, Francesco Stingo, Susan C. Smith, Jan A. Burger, Zeev Estrov, Nitin Jain, Hagop M. Kantarjian, Michael J. Keating

Research output: Contribution to journal › Article › peer-review

205 Scopus citations

Fingerprint

Dive into the research topics of 'Complex karyotype is a stronger predictor than del(17p) for an inferior outcome in relapsed or refractory chronic lymphocytic leukemia patients treated with ibrutinib-based regimens'. Together they form a unique fingerprint.

Medicine & Life Sciences